Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,383 total articles
Grab is no longer just a growth story — recent profitability and a slate of AI-enabled product launches make the Southeast Asian super-app a plausible cash-flow compounder. At a $14.4B market cap, the risk/reward looks attractive for a mid-term swing trade. Entry $3.54, stop $3.20, target $5.50 over ~45 trading days.
Frequency Electronics (FEIM) just pushed above its prior 52-week high on heavy volume and bullish technicals. A $71M backlog, a $20M authorized buyback, and investments in quantum sensing provide a credible growth narrative that could support a multiple expansion. That said, recent uneven revenue and negative free cash flow mean this is a tactical,…
Ranger Energy Services (RNGR) benefits from durable demand for high‑spec mobile rigs and complementary wireline and processing services. Strong Q2 2025 operating results and cash flow metrics give the company optionality and margin stability even if broader drilling activity softens. A mid‑term long trade targets upside toward the 52‑week high whil…
Agenus (AGEN) is a clinical-stage immuno-oncology company trading at a low market cap with active programs in botensilimab/balstilimab combos and several other immune-modulating assets. Recent clinical progress has created asymmetric upside on positive data or partnership news, but the company faces constrained liquidity and negative free cash flow…
Monster (MNST) looks positioned to outperform broader beverage peers as energy drinks outpace traditional cola categories. Strong margins, $2.07B in free cash flow, and bullish technicals argue for a tactical long: entry $86.93, target $99.00, stop $80.00. This trade balances upside from category growth with a clearly defined stop and time horizons…
Meta's Family of Apps is a cash-generative, high-ROE engine trading at reasonable multiples. Reality Labs is a capital-hungry growth bet that caps the multiple for the whole company. A structural separation or clearer capital allocation that isolates RL's volatility would likely re-rate the core business and create near-term upside. Trade idea: buy…
Micron is the poster child of the 2026 memory supercycle: explosive revenue, strong margins, and a fortress-like balance sheet. The stock has surged, yet fundamental cyclicality in DRAM/NAND means upside can be huge in the near-to-mid term while a brutal inventory-driven contraction remains a medium-term risk. This trade idea lays out a concrete en…
<p>Nano Labs is a microcap fabless semiconductor and distributed computing play that has been hammered from a $31.48 52-week high to $2.47 today. The firm is pivoting its balance sheet and product roadmap toward AI infrastructure, tokenization and crypto reserves. With a market cap of roughly $57.3M and a sub-1x book multiple, the shares offer asym…
Axon reported a clean Q1 beat, raised FY guidance, and is showing rapid AI bookings growth. The stock trades near the 20-day average with bullish momentum signals and elevated short interest — a classic setup for a sharp rebound. This trade idea lays out an actionable mid-term (45 trading days) plan with precise entry, stop and target while weighin…
Crocs looks like a classic recovery + cash-flow trade. The Crocs core brand remains cash generative while HeyDude - the main drag - is being cleaned up and guided to stabilize in H2 2026. With free cash flow of $642.9M, an enterprise value of $6.69B and technical momentum turning bullish, this is a directional long for investors willing to hold int…
Freeport-McMoRan gives investors high-leverage exposure to the multi-year copper bull market without paying the equity premium baked into peers like Southern Copper. Operational hiccups at Grasberg and a recent guidance cut create a tactical entry. Trade plan: enter $63.52, stop $58.00, target $72.00 over ~45 trading days.
Ciena is one of the clearest beneficiaries of the AI-data-center buildout: revenue and earnings are growing rapidly, backlog is meaningful, and product demand is broad-based. The problem for traders today is price: the stock trades at elevated multiples (P/E ~360, P/S ~16) and sits near its 52-week high. This trade idea frames a disciplined buy-the…
Transocean's $6.1B backlog, all-stock Valaris acquisition that would create a ~$10B combined backlog, and signs of supply tightness in 2027 create a concrete setup for a long trade. Balance-sheet improvement, positive free cash flow, and improving technicals support a mid-to-long-term move higher; downside is real if oil weakens, the merger runs in…
Nvidia’s fundamentals and cash generation look eerily similar to the conditions that preceded Apple's 2018 re-rating: dominant product cycles, massive free cash flow and a temporary valuation hangover. This trade idea proposes a long entry at $217.25, a $190 stop and a $300 target over a long-term horizon (180 trading days). The plan leans on conti…
RTX's share-price weakness from recent program headlines and short-term execution worries masks durable fundamentals: $8.46B in free cash flow, a $238B market cap, diversified mission-critical franchises, and clear government-driven demand to replenish munitions and air systems. We reiterate Buy with a concrete trade plan: enter $176.00, stop $155.…
Broadcom's unique position designing custom AI ASICs for hyperscalers, combined with strong free cash flow and a history of margin durability, creates a high-conviction trade idea. Valuation is rich, so we size and protect the position with a clear entry, stop and target for a long-term (180 trading days) horizon.
IAC trades at $42.04 with a $3.13B market cap, a deep free-cash-flow profile relative to enterprise value and a management team that has prioritized shareholder-friendly capital allocation. This trade targets a breakout to $52 over a mid-term (45 trading days) horizon with a tight stop to limit downside if the thesis fails.
MaxLinear's April earnings print and bullish Q2 guide sparked a rally that looks like the opening move in a broader rerating driven by hyperscale AI optical demand. The business has meaningful revenue inflection potential, but valuation is rich and legal/earnings history creates headline risk. This trade idea offers a mid-term (45 trading days) lon…
Nvidia's cash flow and dominance in AI infrastructure underpin a tradeable setup. Entry around $216, stop $203, target $265 — mid-term (45 trading days) — risk/reward skewed in favor of upside given FCF, low leverage, and still-healthy technicals despite short-term momentum softness.
Silvercorp combines steady mine production in China, a strong PEA for its Condor gold project, and a reaffirmed dividend as silver demand tightens. Market cap sits at $2.6B with a 52-week range of $3.57-$15.77. This trade targets a return to the $15 area over the next 45 trading days, with a disciplined stop to limit downside risk.
Calumet (CLMT) is showing signs of a structural earnings lift driven by Specialty Products & Solutions and renewable-fuel catalysts. With recent revenue momentum, DOE support for SAF, improving technicals and a manageable free cash flow profile, a mid-term long trade targeting $42 is a practical, risk-controlled way to capture upside while acknowle…
Radcom (RDCM) is a profitable, cash-heavy provider of cloud-native network intelligence and service assurance. Recent results show steady revenue growth (2025 revenue $71.5M, +17.2% YoY), record operating margins and $109.9M cash with no debt. The business sells into long telco procurement cycles; that makes the stock a patient, fundamentally suppo…
Booking Holdings (BKNG) has been punished this year on fears around AI disruption, competition and geopolitics, yet the business still generates ~$9.0B in free cash flow, trades near $161, and sits well below its 52-week high of $233.6. For patient traders, a disciplined long entry offers asymmetric upside with a clear stop and measured targets.
Palantir just reported blowout growth and margins that read like a software winner. The stock is expensive, but fundamentals and improving commercial traction argue for an aggressive long entry. This trade lays out entry, stop, target, time horizon, catalysts and balanced risks for a long-term (180 trading days) swing into PLTR.
TransMedics (TMDX) sold off after a recent earnings surprise, but the company's core organ-care franchise continues to produce strong unit growth, solid free cash flow and attractive valuation ratios versus future growth. This trade idea proposes a tactical long into the weakness with a clear entry, stop and target and a mid-term horizon to let the…
